Glaxosmithkline will have a new head from January

The Pharmaceutical Giant, Glaxosmithkline (GSK) has announced the appointment of Luke Mills as a new chief executive director. He will take office from January 1, 2026. Mills currently holds the position of Commercial Director of the Pharmaceutical Company. Prior to that, he worked in large pharmaceutical companies such as Astrazeneca, Roshi and ...